Christoph Wanner is a Senior Professor of Medicine in the Department of Clinical Studies and Epidemiology, University Hospital of Würzburg and a Visiting Professor of Renal Medicine at the Nuffield Department of Population Health, Clinical Trial Service Unit, University of Oxford UK. His research is in the field of diabetic kidney disease, lipid disorders, and rare kidney diseases with a future focus on maintenance or restoration of kidney health.

He has published more than 950 pubmed referenced scientific papers and articles (Hirsch Index web of science 109, google scholar 145). He has been PI of the 4D study and a steering committee member of the SHARP, the Empagliflozin studies and the FIND CKD study aiming in improving the management of cardiovascular and kidney disease progression and treatment of kidney failure by dialysis. Wanners’ two landmark studies in this field have been published in 2005 (The 4D Study) and in 2015 & 2016 (EMPA-REG Outcome). In 2016 he received the highest awards from the European Renal Association (ERA) and the German Society of Nephrology. Dr. Wanner is currently President of the ERA, being in office June 2020-2024.